Neuronostics
PrivateLast Round
VC Round
Jun 30, 2026
Total Funding Raised
$7.59M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neuronostics is a medical technology company that develops digital biomarkers and software for the diagnosis and prognosis of neurological conditions such as epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuronostics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neuronostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2026 | ||||
| Grant | Sep 4, 2024 | ||||
| Seed | Apr 5, 2024 | ||||
| Grant | Apr 5, 2024 | ||||
| Grant | Apr 5, 2024 | ||||
Pre Seed | Mar 26, 2021 |
Neuronostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Ascension Ventures | VC Round, Seed |
| SBRI Healthcare | Grant |
| QantX | VC Round, Seed, Pre Seed |
| University of Exeter | Corporate Funding, Grant |
| New Wave | VC Round |
| Innovate UK | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$4M raised from Empirical Ventures and The FSE Group.
- Nov 28, 2025
Named Most Transformative HealthTech Company at the OBE awards.
Neuronostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuronostics's valuation, stock price, and market status.